Recent Posts tagged as 'FDA'
Blog Post
04/24/2020
By Jonathan A. Havens

On April 23, 2020, the U.S. District Court for the District of Maryland granted the U.S. Food and Drug Administration’s (FDA or the Agency) request for an extension of the submission deadline for certain deemed tobacco product premarket review applications. FDA requested the extension on March 30, 2020, citing the “extraordinary circumstances” of the COVID-19 outbreak for the delay. The new deadline for applications for premarket review for deemed e-cigarettes, cigars, and other new tobacco products is September 9, 2020.

Blog Post
11/26/2019
By Jonathan A. Havens

On November 25, 2019, the U.S. Food and Drug Administration (FDA or the Agency) announced that it had issued Warning Letters to 15 companies for illegally selling products containing cannabidiol (CBD).

Blog Post
04/04/2019
By Jonathan A. Havens

On April 2, 2019, outgoing U.S. Food and Drug Administration (FDA or the Agency) Commissioner Scott Gottlieb, M.D., further addressed FDA’s approach to cannabis-containing and cannabis-derived products (e.g., cannabidiol (CBD)-containing products).

Blog Post
02/19/2019
By Jonathan A. Havens and Kermit J. Nash

Despite the cold temperatures across much of the country, federal and state policy, regulatory, and enforcement developments have been heating up in the food and beverage space.  In the last few weeks alone:

Pages